TheraPallet

VitalTE LifeSciences is a biotechnology and medical device company specializing in advanced hormone replenishment therapy (HRT) and minimally invasive delivery systems. Founded in 2022 by Dr. Charles Virden, the company is developing long-acting injectable hormone formulations, including testosterone and estradiol, using Likarda's Core-Shell Spherification (CSS) hydrogel technology. This approach aims to provide the efficacy of traditional hormone pellets without the need for surgical implantation. Additionally, VitalTE offers the Atrocar, a patented atraumatic trocar designed to reduce complications such as lacerations and hematomas during pellet insertion. The company is currently conducting IND-enabling studies for its lead injectable programs, with Phase 1 clinical trials anticipated in 2025.